NCF1 and fatty liver disease: Our results suggest that the reduction of ROS production secondary to the absence of neutrophilic NCF1 leads to hepatic activation of SIRT1 and AMPK, shifts the intracellular lipid metabolism toward fatty acid oxidation, and ameliorates alcohol-induced hepatic steatosis.